Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 26, 2022; 10(30): 10896-10905
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.10896
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.10896
Table 3 The relationship between endoscopic severity of Candida esophagitis and clinical symptoms
| Symptoms | Severity (%) | P value | |||
| Grade 1 (n = 11) | Grade 2 (n = 29) | Grade 3 (n = 6) | Grade 4 (n = 1) | ||
| Chest pain | 3 (27.3) | 4 (13.8) | 0 (0) | 0 (0) | 0.564 |
| Abdominal pain | 1 (9.1) | 2 (6.9) | 0 (0) | 0 (0) | 1.000 |
| Dysphagia | 0 (0) | 0 (0) | 0 (0) | 1 (100) | 0.021 |
| Globus | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Acid reflux | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
| Odynophagia | 0 (0) | 0 (0) | 0 (0) | 0 (0) | N/A |
- Citation: Chen YH, Jao TM, Shiue YL, Feng IJ, Hsu PI. Prevalence and risk factors for Candida esophagitis among human immunodeficiency virus-negative individuals. World J Clin Cases 2022; 10(30): 10896-10905
- URL: https://www.wjgnet.com/2307-8960/full/v10/i30/10896.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i30.10896